Rakuten Trade Research Reports
Technical View - Hextar Healthcare Bhd
rakutentrade
Publish date: Tue, 15 Nov 2022, 09:06 AM
rakutentrade
0 1,846
An official blog in I3investor to publish research reports provided by Rakuten Trade research team.
All materials published here are prepared by Rakuten Trade. For latest offers on Rakuten Trade products and news, please refer to: https://www.rakutentrade.my/
To sign up for an account: http://bit.ly/40BNqKI
Rakuten Trade
Hotline: +603 2110 7110 (Account Opening, General enquiry)
Email: customerservice@rakutentrade.my
All materials published here are prepared by Rakuten Trade. For latest offers on Rakuten Trade products and news, please refer to: https://www.rakutentrade.my/
To sign up for an account: http://bit.ly/40BNqKI
Rakuten Trade
Hotline: +603 2110 7110 (Account Opening, General enquiry)
Email: customerservice@rakutentrade.my
Hextar Healthcare Bhd (HEXCARE, 7803)
• Share price closed 2.27% higher at RM0.45 on Monday.
• HEXCARE is pending a breakout from its flag formation. In line with the surge in the glove counters recently, HEXCARE has gained interest for the past 2 trading days with decent buying interests. As MACD crossover and indicators are showing bullish signals, share price is expected to trend higher.
• Resistance levels are identified at RM0.48 (R1) and RM0.49 (R2).
• On the flipside, support levels are pegged at RM0.415 (S1) and RM0.41 (S2).
Source: Rakuten Research - 15 Nov 2022
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on Rakuten Trade Research Reports
Lee Swee Kiat Group Bhd - Sweet Earnings Growth and Sweet Dreams
Created by rakutentrade | Apr 24, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Apps
Top Articles
1
3
4
5
6
save malaysia!
7
8
BFM Podcast
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
